Chemical Structure (Buprenorphine 01)
Buprenorphine Tablet
Product Images NDC 72162-1345
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 72162-1345). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Buprenorphine 02)
Label (Lbl721621345)
Buprenorphine Sublingual Tablets are a medication used for the treatment of opioid dependence. Each tablet contains 8.64 mg of Buprenorphine HCI, equivalent to 8 mg of Buprenorphine. It is important to keep this medication out of reach of children as it may cause drowsiness. The tablets should be stored in a tight, light-resistant container with a child-resistant closure. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F). The medication guide should be provided to each patient. For more information, refer to the provided link. This medication is available in a pack of 30 tablets and should be administered under prescription. The tablets are repackaged by Bryant Ranch Prepack, Inc. and manufactured by Purdue Pharma L.P.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
